WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem licensed a protein inhibitor program of inflammatory disease to Janssen Biotech, Inc. The event triggers a milestone payment to X-chem under their collaboration agreement.
![]()
↧
X-Chem Announces License with Janssen for Protein:Protein Inhibitor Program in Inflammatory Disease
↧